von Moltke Lisa
SEC CIK 1808592 · EDGAR
BoughtSold
Most active insiders at MCRB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Henn Matthew R | See Remarks | — | $23.4K |
| 2 | Young Teresa L. | See Remarks | — | $18.7K |
| 3 | Shaff Eric D. | Dir | — | $9,095 |
| 4 | DesRosier Thomas | See Remarks | — | $2,943 |
| 5 | Brady Kelly | See Remarks | — | $735.47 |
von Moltke Lisa made no open-market trades at MCRB in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-02-19 | 2025-02-15 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | — | +11.9K | 35.4K | +51% | — |
| DT | 2025-02-19 | 2025-02-18 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $0.81 | -4,416 | 39.9K | -10% | -$3,577 |
| DT | 2024-11-19 | 2024-11-15 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | — | +2,969 | 33.4K | +10% | — |
| DT | 2024-11-19 | 2024-11-18 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $0.54 | -977 | 32.4K | -3% | -$527.58 |
| DT | 2024-10-29 | 2024-10-28 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $0.69 | -4,334 | 30.4K | -12% | -$2,990 |
| DT | 2024-10-29 | 2024-10-27 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | $0.00 | +13.7K | 34.8K | +65% | $0 |
| DT | 2024-08-19 | 2024-08-15 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | — | +2,969 | 22.0K | +16% | — |
| DT | 2024-08-19 | 2024-08-16 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $0.84 | -973 | 21.0K | -4% | -$817.32 |
| D | 2024-06-06 | 2024-06-04 | TVRD | Tvardi Therapeutics, Inc. | von Moltke Lisa | Dir | A - Grant | $0.00 | +150.6K | 183.0K | +466% | $0 |
| DT | 2024-05-17 | 2024-05-15 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $0.94 | -939 | 19.0K | -5% | -$882.66 |
| DT | 2024-05-17 | 2024-05-15 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | — | +2,968 | 20.0K | +17% | — |
| DT | 2024-02-16 | 2024-02-15 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | — | +11.9K | 21.4K | +125% | — |
| DT | 2024-02-16 | 2024-02-16 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $1.08 | -4,400 | 17.0K | -21% | -$4,752 |
| D | 2023-10-31 | 2023-10-30 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | S - Sale+OE | $1.35 | -4,232 | 9,513 | -31% | -$5,713 |
| D | 2023-10-31 | 2023-10-27 | MCRB | Seres Therapeutics, Inc. | von Moltke Lisa | See Remarks | M - OptEx | $0.00 | +13.7K | 13.7K | New | $0 |
| D | 2023-06-05 | 2023-06-01 | TVRD | Tvardi Therapeutics, Inc. | von Moltke Lisa | Dir | A - Grant | $0.00 | +32.4K | 32.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations